Aequus Pharmaceuticals (AQS) Price & Analysis

Q: What was Aequus Pharmaceuticals Inc’s price range in the past 12 months?

Aequus Pharmaceuticals Inc lowest stock price was <C$0.01 and its highest was C$0.01 in the past 12 months.

Q: What is Aequus Pharmaceuticals Inc’s market cap?

Aequus Pharmaceuticals Inc’s market cap is C$663.17K.

Q: When is Aequus Pharmaceuticals Inc’s upcoming earnings report date?

Aequus Pharmaceuticals Inc’s upcoming earnings report date is May 06, 2026 which is in 139 days.

Q: How were Aequus Pharmaceuticals Inc’s earnings last quarter?

Aequus Pharmaceuticals Inc released its earnings results on Nov 28, 2025. The company reported C$0.003 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.003.

Q: Is Aequus Pharmaceuticals Inc overvalued?

According to Wall Street analysts Aequus Pharmaceuticals Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Aequus Pharmaceuticals Inc pay dividends?

Aequus Pharmaceuticals Inc does not currently pay dividends.

Q: What is Aequus Pharmaceuticals Inc’s EPS estimate?

Aequus Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Aequus Pharmaceuticals Inc have?

Aequus Pharmaceuticals Inc has 132,634,430 shares outstanding.

Q: What happened to Aequus Pharmaceuticals Inc’s price movement after its last earnings report?

Aequus Pharmaceuticals Inc reported an EPS of C$0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Aequus Pharmaceuticals Inc?

Currently, no hedge funds are holding shares in TSE:AQS

Compare

14 Followers

AQS Stock Chart & Stats

C$0.01

>-C$0.01(-50.00%)

At close: Jan 08 4:00 PM EST

C$0.01

>-C$0.01(-50.00%)

Day’s Range― - ―

52-Week Range<C$0.01 - C$0.02

Previous CloseN/A

Volume10.00K

Average Volume (3M)10.00K

Market Cap

C$663.17K

Enterprise ValueC$0.00

Total Cash (Recent Filing)C$35.08K

Total Debt (Recent Filing)C$6.64M

Price to Earnings (P/E)―

Beta-3.73

Next Earnings

May 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)<0.01

Shares Outstanding132,634,430

10 Day Avg. Volume10,000

30 Day Avg. Volume10,000

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)-0.21

Price to Sales (P/S)2.27

P/FCF Ratio-0.80

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Aequus Pharmaceuticals News

Aequus Pharmaceuticals Clarifies Shareholder Meeting Details Amid Regulatory Disclosures

The latest announcement is out from Aequus Pharmaceuticals ( ($TSE:AQS) ). Aequus Pharmaceuticals has provided additional information regarding...

1M ago

Aequus Pharmaceuticals Updates Shareholders on Key Meeting Details

Aequus Pharmaceuticals ( ($TSE:AQS) ) just unveiled an update. Aequus Pharmaceuticals has provided additional information regarding its upcoming...

1M ago

Aequus Pharmaceuticals Welcomes Giovanni Di Genova to Board of Directors

The latest update is out from Aequus Pharmaceuticals ( ($TSE:AQS) ). Aequus Pharmaceuticals Inc. announced the appointment of...

3M ago

Aequus Pharmaceuticals Sells Zimed® PF to Luvo Medical Technologies

The latest announcement is out from Aequus Pharmaceuticals ( ($TSE:AQS) ). Aequus Pharmaceuticals has announced the sale of...

7M ago

Aequus Pharmaceuticals Sees Revenue Surge in Q1 2025 Amid Cost-Cutting Measures

An update from Aequus Pharmaceuticals ( ($TSE:AQS) ) is now available. Aequus Pharmaceuticals reported a significant increase in...

7M ago

Aequus Pharmaceuticals Reports Fiscal 2024 Results and Director Changes

Aequus Pharmaceuticals ( ($TSE:AQS) ) has shared an announcement. Aequus Pharmaceuticals reported a decrease in operating loss for...

8M ago

Aequus Pharmaceuticals Reports Revenue Growth Amid Restructuring

Aequus Pharmaceuticals (TSE:AQS) has released an update. Aequus Pharmaceuticals reports a 77.50% increase in revenue for Q3 2024...

1y ago

Aequus Pharmaceuticals Reports Strong Q2 Financials

Aequus Pharmaceuticals (TSE:AQS) has released an update. Aequus Pharmaceuticals Inc. has seen a positive second quarter in 2024...

1y ago

Aequus Pharmaceuticals Celebrates Zimed® PF Sales Record

Aequus Pharmaceuticals (TSE:AQS) has released an update. Aequus Pharmaceuticals Inc. reports a record-breaking sales quarter for Zimed® PF,...

1y ago

Aequus to Distribute Innovative Glaucoma Device

Aequus Pharmaceuticals (TSE:AQS) has released an update. Aequus Pharmaceuticals has secured an exclusive deal with Advanced Ophthalmic Innovations...

1y ago

AQS FAQ

What was Aequus Pharmaceuticals Inc’s price range in the past 12 months?

Aequus Pharmaceuticals Inc lowest stock price was <C$0.01 and its highest was C$0.01 in the past 12 months.

What is Aequus Pharmaceuticals Inc’s market cap?

Aequus Pharmaceuticals Inc’s market cap is C$663.17K.

When is Aequus Pharmaceuticals Inc’s upcoming earnings report date?

Aequus Pharmaceuticals Inc’s upcoming earnings report date is May 06, 2026 which is in 139 days.

How were Aequus Pharmaceuticals Inc’s earnings last quarter?

Aequus Pharmaceuticals Inc released its earnings results on Nov 28, 2025. The company reported C$0.003 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.003.

Is Aequus Pharmaceuticals Inc overvalued?

According to Wall Street analysts Aequus Pharmaceuticals Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aequus Pharmaceuticals Inc pay dividends?

Aequus Pharmaceuticals Inc does not currently pay dividends.

What is Aequus Pharmaceuticals Inc’s EPS estimate?

Aequus Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aequus Pharmaceuticals Inc have?

Aequus Pharmaceuticals Inc has 132,634,430 shares outstanding.

What happened to Aequus Pharmaceuticals Inc’s price movement after its last earnings report?

Aequus Pharmaceuticals Inc reported an EPS of C$0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Aequus Pharmaceuticals Inc?

Currently, no hedge funds are holding shares in TSE:AQS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aequus Pharmaceuticals Inc

Aequus Pharmaceuticals Inc. is a specialty pharmaceutical company operating in the healthcare sector, focusing on the development and commercialization of high-quality, differentiated products in ophthalmology and transplant markets. The company aims to address significant unmet medical needs by enhancing the delivery and effectiveness of existing treatments. Aequus leverages its expertise in drug formulation and a robust pipeline of products to improve patient outcomes and quality of life.